Clinical Trials Directory

Trials / Completed

CompletedNCT04533841

Propranolol and Misoprostol Versus Misoprostol Alone for Induction of Labor in Primigravidas

Propranolol and Misoprostol Versus Misoprostol Alone for Induction of Labor In Primigravidas

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Ahmed mohamed fathy ismail · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

To compare propranolol and misoprostol versus misoprostol alone for induction of labour in primigravidas

Detailed description

Candidates will be randomized into 2 groups according to a computer generated sequence. Each candidate will be assigned an opaque sealed envelope containing a paper with her group on it. Both the patient and doctor on duty will be blinded to which group the patient was assigned to. \- Study procedure: 1. Written informed consent will be obtained from all participants prior to the study. 2. Full history taking. 3. General examination. Patients will be subjected to the following: * Patients attending labour room for induction of labour will be divided into two groups. * Both groups, women are induced with Tab misoprostol 25μg applied to posterior vaginal fornix under aseptic precaution and every 6 hours for a maximum of 4 doses. * In group 1, after induction is started with misoprostol placement, 30 minutes will pass before administration of oral Propanolol 20mg * In group 2, after induction is started with misoprostol placement, 30 minutes will pass before administration of oral placebo in the form of sugary tablets. * After induction, women will be monitored for fetal and maternal wellbeing and progress of labour.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostolPt will receive misoprostol for labor induction then after 30 minutes will receive ether propranolol or misoprostol
DRUGPlaceboplacebo
DRUGPropranololPropranolol

Timeline

Start date
2020-02-01
Primary completion
2020-09-13
Completion
2020-09-15
First posted
2020-09-01
Last updated
2022-08-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04533841. Inclusion in this directory is not an endorsement.